attempt to explain differences which statistically do not exist. Looking briefly at your results the variation by histological type seems real, but that by gender is consistent with chance variation. 4 .
It is unclear whether the authors only used effect estimates provided directly in the publications or whether they derived some estimates from data provided. For example, if the authors presented estimates for current and former smoking, it is possible (using the methodology of Hamling et al1) to derive an effect estimate for ever smoking. 5 .
At the end of the introduction it is stated that the authors "sought to provide a summary of available literature of high quality…". It is also stated that the studies were graded for quality using the Newcastle-Ottawa Scale. However, there is no definition of what constitutes "high" quality, or whether any studies were rejected on the basis of low quality. 6 .
The authors refer in the information to a previous metaanalysis by Xu et al involving 28 case-control studies and four cohort studies. The present paper includes 17 case-control studies and four cohort studies. The paragraph refers to nine of Xu"s studies that were excluded for various reasons, and to four new studies. This would explain why the number of studies in the present review is smaller by 5 (9−4), but not why it is smaller by 11 (28−17). Some explanation is needed.
7.
Selection of pack-years as the only dose-response measure in Table 3 seems strange, especially as it is a combination of two distinct dimensions (daily consumption and years smoked) which may have differing relationships to NPC risk. It would be useful to see results by consumption and duration separately. 8.
There seemed to be no legends for the Figures (at least in the material provided to me for review). 9.
The Tables are referred to in the text as I, II and III, but are  headed 1, 2 and 3.  10. A figure (2) is provided showing results for ever smokers. It would be useful to see also figures for current and former smoking. 11.
It seems bizarre that in the dose-response analysis reference is made to a linear relationship with pack-years when the graph shown to illustrate this shows a curved relationship. Perhaps it would be useful to show the fitted line in the figure. Reference to "cumulative number of pack-years" is incorrect. Pack-years itself is a cumulative measure. 12.
In paragraph 4, there is the phrase "pointless in terms of statistics". What does this mean? 13. In the sensitivity analysis, the study of Ji 2001 is removed. It is stated that the between-study heterogeneity dropped strikingly, but it should be made clear whether it remained statistically significant. Looking at Figure 1 it also seems that Turkoz 2001 is a clear outlier. It would be of interest to see whether removing that also reduced (and perhaps eliminated) the significant heterogeneity. 14. Table 3 refers to "age of onset". To avoid a reader thinking this might refer to "age of onset of NPC", call it "age of onset of smoking". 15.
The English, though clear enough, could be improved in a number of places.Introduction -Para 1 -line 2 "Despite NPC being rare ….." 7.
Introduction -Para 2 -line 2 "for the occurrence ….." 8.
Introduction -Para 2 -line 5 "….. some studies failing to find ….." Reference 1. Hamling J, Lee P, Weitkunat R, Ambühl M. Facilitating metaanalyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008;27:954-70.
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GENERAL COMMENTS
The manuscript ""Cigarette Smoking and the Risk of Nasopharyngeal carcinoma: A Meta-Analysis of Epidemiological Studies"" by Mengjuan Long and colleagues presents cigarette smoking is one of the risk factors of nasopharyngeal carcinoma (NPC). The manuscript is well written and the analysis is well conducted in large. I think that Epstein-Barr virus (EBV) is the most important factor in the patients with NPC. In the NPC case not related to EBV, smoking can be the risk factor of NPC.
Here are the minor comments.
1) The authors should present the characteristic of EBV in the Table. 2) NPC has the regionality. Are there regionalities in NPC caused by smoking? Response: We agree that any competing interests should be stated. Thus, we have provided this information and stated "None declared" in the revised manuscript (Marked copy-Page 16, Line 9).
VERSION 1 -AUTHOR RESPONSE

Reviewer 1 COMMENTS FOR THE AUTHOR:
While this paper describes a careful and detailed review of the evidence on smoking and nasopharyngeal carcinoma it could be improved in a number of ways, as summarized below:
1. There is some confusion between the terms nonsmoker and never smoker. In strict English, a nonsmoker is someone who does not currently smoke, and therefore includes former smokers. However, I am fairly sure that the authors mean lifelong nonsmokers when they say nonsmokers. I would get round the problem by initially referring to "lifelong nonsmokers (i.e. never smokers)" and then using the term "never smokers" consistently afterwards.
Response: We agree and have reworded the term "nonsmoker" to "never smoker" throughout the revised manuscript.
2. Related to this is the unmentioned problem of "never smoker of what?" Are we talking of never smokers of cigarettes (which may include pipe or cigar smokers) or never smokers of any tobacco product? The same problem arises with the definition of cigarette smoking. Are results equally acceptable for those who smoke cigarettes only, or who are mixed smokers of cigarettes and other products? What about studies who only present results for smoking of any product?
Response: In our research, never smokers meant that people did not smoke any tobacco product. We have added this definition in the revised manuscript (Marked copy-Page 6, Line 17-18). Three of 21 eligible studies presented results for smoking of different tobacco products, and we extracted data for smoking cigarettes only. The other 18 studies referred to cigarette smokers and did not mention pipes or cigars or any other tobacco products. Since data about mixed smokers of cigarettes and other products was scare, we could not address this issue in the current meta-analysis. However, we agree this is an important question warrants further research, thus, we mentioned this as a limitation of our manuscript in the revised manuscript (Marked copy-Page 15, Line 12-13). Table 3 do not (and should) include tests of significance of heterogeneity over levels of a factor. It is inappropriate, for example, to carry out separate analyses for males and females, find that estimates are significant for males but not for females, and then emphasise this in the discussion, if in fact there is no significant variation by gender in the effect estimates. The proper analysis is to first test whether effect estimates vary significantly by gender, and then only emphasise differences if they do. If there is no significant variation, simply say that there was no significant evidence of variation by gender. It is a gross error to attempt to explain differences which statistically do not exist. Looking briefly at your results the variation by histological type seems real, but that by gender is consistent with chance variation.
The analyses described in
Response: The results presented in Table III showed heterogeneity of data among eligible studies included in each stratified analysis. We did not test whether effect estimates vary significantly by levels of a selected factor.
For example, heterogeneity among 19 studies referred to the pooled OR and its 95%CI for ever smokers was 1.56 (1.32-1.83), and heterogeneity of the ORs for ever smokers among 19 studies was 66.8%. There was significant heterogeneity in ORs for ever smokers among 19 studies (P value was <0.01). Table 3 did not show whether effect estimates vary significantly by levels of smoking (i.e. current smoker versus former smokers).
4. It is unclear whether the authors only used effect estimates provided directly in the publications or whether they derived some estimates from data provided. For example, if the authors presented estimates for current and former smoking, it is possible (using the methodology of Hamling et al1) to derive an effect estimate for ever smoking.
Response: As for publications without available effect sizes, crude effect estimates and 95% CIs were directly derived from data provided (for example: N, sample size for different groups). Since most of the studies provided effect estimate for ever smoking directly, we did not use the methods mentioned in Hamling"s article. These had been stated in Methods section in the revised manuscript (Marked copy-Page 6, Line 5-7).
5. At the end of the introduction it is stated that the authors "sought to provide a summary of available literature of high quality…". It is also stated that the studies were graded for quality using the Newcastle-Ottawa Scale. However, there is no definition of what constitutes "high" quality, or whether any studies were rejected on the basis of low quality.
Response: We agree that the term "high quality" was not appropriate in the text and thus was deleted. The sentence has been rewritten in the revised manuscript (Marked copy-Page 5, Line 1).
6. The authors refer in the information to a previous meta-analysis by Xu et al involving 28 casecontrol studies and four cohort studies. The present paper includes 17 case-control studies and four cohort studies. The paragraph refers to nine of Xu"s studies that were excluded for various reasons, and to four new studies. This would explain why the number of studies in the present review is smaller by 5 (9−4), but not why it is smaller by 11 (28−17). Some explanation is needed. Another one (Ma 2011) was excluded after reviewing its abstract for it mainly described functional gene polymorphism and risk of NPC and did not provide data for relationships between cigarette smoking and NPC risk, which did not conform with our strict selection criteria. As a result, there were total of 15 studies excluded and four new studies were added (15-4=11).
7. Selection of pack-years as the only dose-response measure in Table 3 seems vstrange, especially as it is a combination of two distinct dimensions (daily consumption and years smoked) which may have differing relationships to NPC risk. It would be useful to see results by consumption and duration separately.
Response:
We have tried to analyze relationships of daily consumption and duration to NPC risk separately. However, most eligible studies did not provide data for duration. Consequently, we decided to see results by pack-years and intensity of smoking (i.e. daily consumption) respectively, which could indicate the effects for duration to a certain degree.
8. There seemed to be no legends for the Figures (at least in the material provided to me for review).
Response: We have edited legends for our figures and uploaded them as images.
9. The Tables are referred to in the text as I, II and III, but are headed 1, 2 and 3.
Response: We agree and have corrected them in the tables. Response: We have compared the relationship between current/former smokers and the risk of NPC development, and the results were displayed in the Table III . However, we did not present their funnel plots because our research already had five figures.
11. It seems bizarre that in the dose-response analysis reference is made to a linear relationship with pack-years when the graph shown to illustrate this shows a curved relationship. Perhaps it would be
